Lan Shi
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
-
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
-
- Histone Deacetylase Inhibitors Research 3
- FOXO transcription factor regulation 2
- Wnt/β-catenin signaling in development and cancer 2
- Ubiquitin and proteasome pathways 1
- Protein Degradation and Inhibitors 1
- Oncology 6
- Cancer Cells and Metastasis 3
- Co-authors
- Chunping Liu (10 shared papers)Tao Huang (7 shared papers)Xiu Nie (4 shared papers)Jie Ming (4 shared papers)Xia Xu (1 shared paper)Qunzi Zhao (1 shared paper)Peixian Zhang (3 shared papers)Bin Sun (1 shared paper)
- Journals
- Medicine (1 paper)npj Precision Oncology (1 paper)Journal of Cellular Biochemistry (1 paper)Molecular Therapy — Oncolytics (1 paper)BMC Cancer (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lan Shi
25 papers receiving 476 citations
Peers
Comparison fields: 5 of 48
- Endocrinology, Diabetes and Metabolism 205
- Oncology 139
- Cancer Research 57
- Immunology 64
- Molecular Biology 123
Countries citing papers authored by Lan Shi
This map shows the geographic impact of Lan Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Shi more than expected).
Fields of papers citing papers by Lan Shi
This network shows the impact of papers produced by Lan Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Shi. The network helps show where Lan Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Lan Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 140 | |
| 2 | 2019 | 84 | |
| 3 | 2010 | 46 | |
| 4 | 2012 | 35 | |
| 5 | Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma. | 2015 | 25 |
| 6 | Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma. | 2014 | 21 |
| 7 | Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer. | 2015 | 21 |
| 8 | 2020 | 16 | |
| 9 | 2013 | 14 | |
| 10 | Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma. | 2015 | 13 |
| 11 | 2020 | 12 | |
| 12 | 2022 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2024 | 6 | |
| 15 | 2009 | 6 | |
| 16 | 2013 | 5 | |
| 17 | 2019 | 4 | |
| 18 | 2025 | 3 | |
| 19 | 2009 | 2 | |
| 20 | [Operation for differentiated thyroid cancer: a experience of 546 cases]. | 2008 | 2 |
About Lan Shi
Lan Shi is a scholar working on Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Cancer Research, having authored 26 papers that have together received 479 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (6 papers), Cancer Cells and Metastasis (3 papers), Histone Deacetylase Inhibitors Research (3 papers), FOXO transcription factor regulation (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Ubiquitin and proteasome pathways (1 paper), Cancer Genomics and Diagnostics (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (205 citations), Oncology (139 citations), Cancer Research (57 citations), Immunology (64 citations) and Molecular Biology (123 citations). Lan Shi has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Chunping Liu, Tao Huang, Xiu Nie, Jie Ming, Xia Xu, Qunzi Zhao, Peixian Zhang, Bin Sun, Xudong Zhao and Hongjiu Dai. Their work appears in journals such as Medicine, npj Precision Oncology, Journal of Cellular Biochemistry, Molecular Therapy — Oncolytics and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.